Mobile

A clinical study involving children up to age of 12 years with severe hemophilia A, to look at how safe an experimental replacement factor VIII protein (known as rFVIIIFc) is to take and how well it w...

Update Il y a 5 ans
Reference: EUCTR2011-003073-28

A clinical study involving children up to age of 12 years with severe hemophilia A, to look at how safe an experimental replacement factor VIII protein (known as rFVIIIFc) is to take and how well it works to prevent and stop bleeds

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective of the study is to evaluate safety of rFVIIIFc in previously treated pediatric subjects with hemophilia A.

Inclusion criteria

  • Severe Hemophilia A

Links